SCHEMBL30469098

SCHEMBL30469098

CC(C)(C)OC(=O)NCc1nn(C2CCC(F)(F)CC2)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 1/20 0.46
▸ TEAD4 Q15561 1/20 0.46
▸ TEAD2 Q15562 1/20 0.46
▸ IL1B P01584 4/20 0.40
▸ P2RX7 Q99572 4/20 0.40
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ BRD4 O60885 2/20 0.38
▸ NAMPT P43490 1/20 0.38
▸ GLP1R P43220 1/20 0.37
▸ SSTR4 P31391 1/20 0.37
▸ GFER P55789 1/20 0.37
▸ ACACB O00763 2/20 0.37
▸ ACACA Q13085 1/20 0.37
▸ CYP2D6 P10635 3/20 0.37
▸ CYP1A2 P05177 2/20 0.36
▸ KCNJ6 P48051 1/20 0.36
▸ KCNJ5 P48544 1/20 0.36
▸ KCNJ3 P48549 1/20 0.36
▸ KDM5A P29375 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25678135 1.00 TEAD1 (0.46) TEAD1TEAD4TEAD2IL1BP2RX7
SCHEMBL25236489 0.84 TEAD1 (0.52) TEAD1TEAD4TEAD2IL1BP2RX7
SCHEMBL30469084 0.81 TEAD1 (0.46) TEAD1TEAD4TEAD2IL1BP2RX7
SCHEMBL25234036 0.81 TEAD1 (0.46) TEAD1TEAD4TEAD2IL1BP2RX7
SCHEMBL25678129 0.76 TEAD1 (0.53) TEAD1TEAD4TEAD2KCNJ6KCNJ5
Trifluoroacetic Acid SCHEMBL25278948 0.75 TEAD1 (0.51) TEAD1TEAD4TEAD2KCNJ6KCNJ5
SCHEMBL25679235 0.71 TEAD1 (0.45) TEAD1TEAD4TEAD2HDAC10HDAC6
SCHEMBL30469093 0.71 TEAD1 (0.45) TEAD1TEAD4TEAD2HDAC10HDAC6
SCHEMBL31215192 0.71 SSTR4 (0.42) IL1BP2RX7BRD4NAMPTGLP1R
SCHEMBL25243401 0.71 TEAD1 (0.42) TEAD1TEAD4TEAD2HDAC10HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4452936-A2 INDOLES, INDAZOLES, AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD The Katholieke Universiteit Leuven (BE) 2024-10-30 — — EP disclosed
WO-2023122782-A2 INDOLES, INDAZOLES, AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 — — WO disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD2, TEAD3 TEAD1 4/4885TEAD4 5/4885TEAD2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback